Published in
American Society of Hematology, Blood, 17(131), p. 1955-1959
DOI: 10.1182/blood-2017-11-818286
Links
Tools
Early-onset invasive aspergillosis and other fungal infections in patients treated with ibrutinib
Journal article published in 2018 by
David Ghez,
Laetitia Souchet,
Malgorzata Truchan-Graczyk,
Loïc Ysebaert,
Anne Calleja,
Caroline Protin,
Marine Baron 
,
Marie-Pierre Ledoux,
Ledoux Mp,
Gandhi Damaj,
Mathieu Dupont,
Brigitte Dreyfus,
Emmanuelle Ferrant,
Charles Herbaux,
Kamel Laribi
and other authors.
,
Marie-Pierre Ledoux,
Ledoux Mp,
Gandhi Damaj,
Mathieu Dupont,
Brigitte Dreyfus,
Emmanuelle Ferrant,
Charles Herbaux,
Kamel Laribi
and other authors.
Distributing this paper is prohibited by the publisher
Full text: Unavailable
Preprint: archiving forbidden
Published version:
archiving forbidden
Data provided by 
Abstract
Key Points Ibrutinib may be associated with invasive fungal infections especially IA. Most infections usually occur during the first months of treatment, often in patients with other risk factors for fungal infections.